Showing results (161-170 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|June 25, 2005
Squalamine: a polyvalent drug of the future?Jean Michel Brunel, Chanaz Salmi, Celine Loncle, et al.Current Cancer Drug Targets|June 25, 2005
The MYCN oncogene as a specific and selective drug target for peripheral and central nervous system tumorsAndrea Pession, Roberto TonelliCurrent Cancer Drug Targets|October 8, 2003
Structure and functional relationships of Hsp90Chrisostomos Prodromou, Laurence H PearlCurrent Cancer Drug Targets|February 22, 2005
Novel antisense anti-MDM2 mixed-backbone oligonucleotides: proof of principle, in vitro and in vivo activities, and mechanismsRuiwen Zhang, Hui Wang, Sudhir AgrawalCurrent Cancer Drug Targets|February 18, 2004
Prostate cancer prevention by silibininRana P Singh, Rajesh AgarwalCurrent Cancer Drug Targets|February 18, 2004
Stress signaling from irradiated to non-irradiated cellsE I Azzam, S M de Toledo, J B LittleCurrent Cancer Drug Targets|February 18, 2004
A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapyS Mazumder, E L DuPree, A AlmasanCurrent Cancer Drug Targets|February 18, 2004
Protein kinase CK2 as regulator of cell survival: implications for cancer therapyG M Unger, A T Davis, J W Slaton, et al.Current Cancer Drug Targets|February 18, 2004
Novel targeting of apoptosis pathways for prostate cancer therapyJason B Garrison, Natasha KyprianouCurrent Cancer Drug Targets|August 12, 2008
The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasionYih-Wen Chen, Christina Tekle, Oystein FodstadPageof 187